Published in Nucleic Acids Res on September 25, 1993
Deubiquitination of NF-κB by Ubiquitin-Specific Protease-7 promotes transcription. Proc Natl Acad Sci U S A (2012) 1.06
The Dorsal Rel homology domain plays an active role in transcriptional regulation. Mol Cell Biol (2002) 0.86
Conformational changes induced by DNA binding of NF-kappa B. Nucleic Acids Res (1995) 0.83
I(kappa)B(gamma) inhibits DNA binding of NF-kappaB p50 homodimers by interacting with residues that contact DNA. Mol Cell Biol (1996) 0.78
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell (1986) 15.30
Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell (1988) 11.62
The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product. Cell (1990) 9.37
Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B. Nature (1990) 9.31
Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal. Cell (1990) 9.24
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell (1991) 6.63
Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell (1991) 6.49
The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted alpha helices: crystal structure of the protein-DNA complex. Cell (1992) 6.47
The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO J (1991) 6.08
I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev (1992) 5.67
Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. Science (1991) 5.52
Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Nature (1991) 5.07
Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell (1990) 4.37
Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol Cell Biol (1992) 4.36
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. Mol Cell Biol (1992) 4.03
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell (1991) 3.84
The precursor of NF-kappa B p50 has I kappa B-like functions. Cell (1992) 3.82
Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1991) 3.80
A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes. Proc Natl Acad Sci U S A (1987) 3.80
The graded distribution of the dorsal morphogen is initiated by selective nuclear transport in Drosophila. Cell (1989) 3.77
Dorsal, an embryonic polarity gene in Drosophila, is homologous to the vertebrate proto-oncogene, c-rel. Science (1987) 3.74
Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit. Cell (1992) 3.73
A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Mol Cell Biol (1992) 3.63
Diamide, a new reagent for the intracellular oxidation of glutathione to the disulfide. Biochem Biophys Res Commun (1969) 3.55
Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev (1992) 3.47
Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus. EMBO J (1993) 3.30
Generation of p50 subunit of NF-kappa B by processing of p105 through an ATP-dependent pathway. Nature (1991) 3.26
I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell (1992) 3.25
Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res (1992) 3.22
The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression. Proc Natl Acad Sci U S A (1992) 3.09
Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA. Nature (1990) 2.97
Design of DNA-binding peptides based on the leucine zipper motif. Science (1990) 2.84
Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci U S A (1992) 2.72
NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science (1992) 2.69
The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Proc Natl Acad Sci U S A (1992) 2.56
Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B. Nature (1992) 2.50
Cytoplasmic retention, DNA binding and processing of the NF-kappa B p50 precursor are controlled by a small region in its C-terminus. EMBO J (1991) 2.39
Sequence-specific DNA binding by a short peptide dimer. Science (1990) 2.39
I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity. Genes Dev (1992) 2.36
Altered protein conformation on DNA binding by Fos and Jun. Nature (1990) 2.34
Equilibrium dissociation and unfolding of the Arc repressor dimer. Biochemistry (1989) 2.27
The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50. EMBO J (1992) 2.19
Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. Genes Dev (1992) 2.12
The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein. Mol Cell Biol (1992) 1.99
N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65. Mol Cell Biol (1993) 1.75
The DNA binding arm of lambda repressor: critical contacts from a flexible region. Science (1991) 1.58
Recognition of the adenovirus type 2 origin of DNA replication by the virally encoded DNA polymerase and preterminal proteins. EMBO J (1992) 1.52
Purified I kappa B-beta is inactivated upon dephosphorylation. J Biol Chem (1992) 1.50
Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B. Nucleic Acids Res (1993) 1.43
Structure of a mammalian c-rel protein deduced from the nucleotide sequence of murine cDNA clones. Oncogene Res (1989) 1.41
DNA-induced increase in the alpha-helical content of C/EBP and GCN4. Biochemistry (1991) 1.31
Sequence requirement for specific interaction of an enhancer binding protein (EBP1) with DNA. Nucleic Acids Res (1989) 1.29
Identification and purification of EBP1: a HeLa cell protein that binds to a region overlapping the 'core' of the SV40 enhancer. Genes Dev (1988) 1.27
Enhancer binding protein (EBP1) makes base and backbone contacts over one complete turn of the DNA double helix. J Mol Biol (1989) 1.19
Solution structure of the basic region from the transcriptional activator GCN4. Biochemistry (1991) 1.15
Thermal unfolding studies of a leucine zipper domain and its specific DNA complex: implications for scissor's grip recognition. Biochemistry (1990) 1.14
Molecular insights into human immunodeficiency virus type 1 pathogenesis. Curr Opin Immunol (1992) 0.93
Dynamic filtering by two-dimensional 1H NMR with application to phage lambda repressor. Proc Natl Acad Sci U S A (1984) 0.89
Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science (1990) 8.91
A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell (2000) 6.14
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet (2000) 4.72
Variations in behavior and condition of a Southern Ocean top predator in relation to in situ oceanographic conditions. Proc Natl Acad Sci U S A (2007) 3.04
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med (1999) 3.03
Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland. Am J Hum Genet (2000) 2.22
European Y-chromosomal lineages in Polynesians: a contrast to the population structure revealed by mtDNA. Am J Hum Genet (1998) 1.87
'Active learning in the UK undergraduate dental course'. Br Dent J (1994) 1.71
Almost two centuries with amalgam: where are we today? J Am Dent Assoc (1994) 1.68
Genetic evidence for a family-based Scandinavian settlement of Shetland and Orkney during the Viking periods. Heredity (Edinb) (2005) 1.59
Delayed visual maturation: ophthalmic and neurodevelopmental aspects. Dev Med Child Neurol (1990) 1.55
Nasogastric drug administration. Prof Nurse (1998) 1.40
Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol (2001) 1.38
Single incision laparoscopic surgery in general surgery: a review. Ann R Coll Surg Engl (2011) 1.36
An evaluation of accelerated Portland cement as a restorative material. Biomaterials (2002) 1.31
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer (2002) 1.26
Enhancer binding protein (EBP1) makes base and backbone contacts over one complete turn of the DNA double helix. J Mol Biol (1989) 1.19
Amiodarone and psychiatric symptoms. Br J Psychiatry (1999) 1.10
A clinical evaluation of ophthalmic assessment in children with sensori-neural deafness. Child Care Health Dev (2003) 1.00
Procedurally similar competitive immunoassay systems for the serodiagnosis of Babesia equi, Babesia caballi, Trypanosoma equiperdum, and Burkholderia mallei infection in horses. J Vet Diagn Invest (2000) 1.00
Oral vs intravenous paracetamol for lower third molar extractions under general anaesthesia: is oral administration inferior? Br J Anaesth (2012) 0.99
Unemployment and child abuse. Br Med J (Clin Res Ed) (1987) 0.99
Relationships between walk/run performance and cardiorespiratory fitness in adolescents who are overweight. Phys Ther (2001) 0.94
Juvenile diabetes mellitus and the HLA system. Transplant Proc (1979) 0.94
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol (2001) 0.94
An intervention programme to establish regular toothbrushing: understanding parents' beliefs and motivating children. Int Dent J (2000) 0.92
Role of preterminal protein processing in adenovirus replication. J Virol (1997) 0.90
Cephalic kinetics of intra-arterially injected lidocaine. Oral Surg Oral Med Oral Pathol (1977) 0.90
The multiplication of three different isolates of group B streptococci in pregnant mice. Placenta (1981) 0.88
Disability in children from different ethnic populations. Child Care Health Dev (2002) 0.88
Fiber-laser-based frequency comb with a tunable repetition rate. Opt Express (2004) 0.87
A complex containing betaTrCP recruits Cdc34 to catalyse ubiquitination of IkappaBalpha. FEBS Lett (1999) 0.87
Physiotherapy for the spastic child: an evaluation. Dev Med Child Neurol (1973) 0.87
Vincristine-induced bilateral vocal cord paralysis in children. Pediatr Blood Cancer (2007) 0.87
Large granular lymphocyte proliferation with the natural killer-cell phenotype. Am J Clin Pathol (1992) 0.86
An evaluation of lycra garments in the lower limb using 3-D gait analysis and functional assessment (PEDI). Gait Posture (2000) 0.86
Innominate artery pseudoaneurysm presenting as a widened mediastinum. J Thorac Cardiovasc Surg (1995) 0.85
Chickenpox in mid-trimester pregnancy: always innocent? Dev Med Child Neurol (1996) 0.84
Long-term photoepilation using a broad-spectrum intense pulsed light source. Arch Dermatol (2000) 0.84
Salinity adaptation and gene profiling analysis in the European eel (Anguilla anguilla) using microarray technology. Gen Comp Endocrinol (2007) 0.84
Real time measurement of gene expression in living endocrine cells. Endocrinology (1994) 0.84
Conformational changes induced by DNA binding of NF-kappa B. Nucleic Acids Res (1995) 0.83
Mothers with severe mental illness caring for children. J Nerv Ment Dis (1995) 0.82
Parents with severe mental illness and their children: the need for human services integration. J Ment Health Adm (1994) 0.82
Ability for Aedes albopictus (Diptera: Culicidae) to survive at the climatic limits of its potential range in eastern Australia. J Med Entomol (2014) 0.80
Cardiac effects induced by chemically activated neurons in canine intrathoracic ganglia. Am J Physiol (1990) 0.79
Cross-coherence measurements of supercontinua generated in highly-nonlinear, dispersion shifted fiber at 1550 nm. Opt Express (2004) 0.79
In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors. Neuropeptides (2002) 0.79
Do repeated blood transfusions prevent successful transplantation in highly sensitized potential transplant recipients? Transplant Proc (1982) 0.79
Studies on plaque fluoride after use of F-containing dentifrices. Adv Dent Res (1994) 0.79
Aedes albopictus (Diptera: Culicidae) as a potential vector of endemic and exotic arboviruses in Australia. J Med Entomol (2014) 0.78
Treatment of renal failure in a non-specialist unit. Br Med J (1980) 0.78
Are temporal characteristics of fast repetitive oscillating movement invariant? Percept Mot Skills (2003) 0.78
Botulinum toxin for cerebral palsy; where are we now? Arch Dis Child (2004) 0.78
Age-related changes in force and power associated with balance of women in quiet bilateral stance on a firm surface. Homo (2012) 0.78
Clinical and pathophysiologic correlates of 1064-nm Nd:Yag laser treatment of reticular veins and venulectasias. Arch Dermatol (2001) 0.78
Automated coaching to help parents increase their children's brushing frequency: an exploratory trial. Community Dent Health (2013) 0.76
Continuous infusion of pyridostigmine for myasthenic crisis. Crit Care Med (1994) 0.76
Dental materials: 1991 literature review. J Dent (1993) 0.76
Trade systems in less-developed countries. Lancet (2001) 0.75
Increased inhibitory action against adenosine 5'-triphosphate in the isolated taenia of the guinea-pig caecum by substitution in the A-ring of 2-phenylisatogen. Br J Pharmacol (1983) 0.75
Large granular lymphocyte proliferation: an analysis of T-cell receptor gene arrangement and expression and the effect of in vitro culture with inducing agents. Blood (1988) 0.75
The chamber scarification test. Contact Dermatitis (1996) 0.75
War on white coats. Lancet (2007) 0.75
Questioning the need for anonymous genetic counseling and testing. Am J Hum Genet (1996) 0.75
Leptomeningeal melanoma and multiple cutaneous melanocytic naevi. Br J Dermatol (2007) 0.75
Determination of platinum in urine, ultrafiltrate, and whole plasma by isotope dilution gas chromatography-mass spectrometry compared to electrothermal atomic absorption spectrometry. Anal Biochem (1993) 0.75
Smear campaign. Nurs Times (1989) 0.75
Complete typing of the HLA region in families. III. Analysis of responses in the primed lymphocyte test (PLT). Transplant Proc (1977) 0.75
The British Medical Association--a toothless lion. Lancet (2009) 0.75
Lipid and lipoprotein distributions in octo- and nonagenarians. Metabolism (1979) 0.75
A comparison of the shear bond strength of composite resin bonded by a fourth and a fifth generation dental adhesive to bovine teeth. Prim Dent Care (1999) 0.75
Regulatory effects of S-100 protein and parvalbumin on protein kinases and phosphoprotein phosphatases from brain and skeletal muscle. Mol Cell Biochem (1986) 0.75
Complete typing of the HLA region in families. IV. The genetics of HLA-D as seen by the HTC and PLT methods. Transplant Proc (1977) 0.75
Operating room hazards symposium. How much are we exposed to? J Ky Med Assoc (1975) 0.75
Fusidic acid as a potential antistaphylococcal agent. N Z Med J (1999) 0.75
Intra-HLA recombinations in juvenile diabetes mellitus (JDM) [proceedings]. Diabete Metab (1976) 0.75
A new conceptual model of asymmetry in motor performance for bidimensional fast-oscillating movements in selected variants of performance. Percept Mot Skills (2000) 0.75
Modulation of the catalytic subunit of cyclic AMP-dependent protein kinase by calmodulin, S-100 protein, parvalbumin and troponin. Cytobios (1986) 0.75
Outcomes of father involvement in pregnancy and birth. Birth (1983) 0.75
Mental health. Hitting out. Nurs Times (1987) 0.75
Intermanual temporal differences in bimanual simple isometric coupling by instructions. Percept Mot Skills (2009) 0.75
Genomic analysis of chromosome 22 in synchronous and histologically distinct intracranial tumours in a child. Neuropathol Appl Neurobiol (2010) 0.75
Laboratory science and public health at CDC. MMWR Morb Mortal Wkly Rep (2006) 0.75
Probable occurrence of brain basic protein factor I, an activator of phosphoprotein phosphatases. Cytobios (1986) 0.75
Lateral difference in reaction times to lateralized auditory stimuli. Indian J Physiol Pharmacol (2001) 0.75
Lateralized regular spatial patterns in oscillating drawing arm movements of right-handed young women. Percept Mot Skills (2004) 0.75
HLA studies in families with juvenile diabetes [proceedings]. Diabete Metab (1976) 0.75
A comparative clinical and histologic study of hair transplantation using Er:YAG, Er:YAG/CO2, and standard punch techniques. Dermatol Surg (2001) 0.75
Humanitarian issues. Young people affected by HIV must be supported year in, year out. BMJ (1998) 0.75
Dental materials: 1992 literature review. J Dent (1994) 0.75
Dental materials: 1993 literature review. J Dent (1995) 0.75